Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease.

White AJ, Wijeyekoon RS, Scott KM, Gunawardana NP, Hayat S, Solim IH, McMahon HT, Barker RA, Williams-Gray CH.

Front Neurol. 2018 Nov 20;9:946. doi: 10.3389/fneur.2018.00946. eCollection 2018.

2.

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis.

Wijeyekoon RS, Kronenberg-Versteeg D, Scott KM, Hayat S, Jones JL, Clatworthy MR, Floto RA, Barker RA, Williams-Gray CH.

Front Neurol. 2018 Oct 16;9:870. doi: 10.3389/fneur.2018.00870. eCollection 2018.

3.

Abnormalities of age-related T cell senescence in Parkinson's disease.

Williams-Gray CH, Wijeyekoon RS, Scott KM, Hayat S, Barker RA, Jones JL.

J Neuroinflammation. 2018 May 28;15(1):166. doi: 10.1186/s12974-018-1206-5.

4.

Associations between Lifestyle Factors and Parkinson's Disease in an Urban Sri Lankan Clinic Study.

Wijeyekoon R, Suriyakumara V, Gamage R, Fernando T, Jayasuriya A, Amarasinghe D, Gunasekara H, Sirisena D, Amaratunga D, Muthukuda C, Barker RA, Williams-Gray C, De Silva R.

Int Arch Med. 2017 Sep 15;10. pii: 246. doi: 10.3823/2516.

5.

α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function.

Kuan WL, Bennett N, He X, Skepper JN, Martynyuk N, Wijeyekoon R, Moghe PV, Williams-Gray CH, Barker RA.

Exp Neurol. 2016 Nov;285(Pt A):72-81. doi: 10.1016/j.expneurol.2016.09.003. Epub 2016 Sep 12.

PMID:
27632900
6.

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).

Williams-Gray CH, Wijeyekoon R, Yarnall AJ, Lawson RA, Breen DP, Evans JR, Cummins GA, Duncan GW, Khoo TK, Burn DJ, Barker RA; ICICLE-PD study group.

Mov Disord. 2016 Jul;31(7):995-1003. doi: 10.1002/mds.26563. Epub 2016 Mar 21.

7.

HaNDL with care.

Fernandez N, Wijeyekoon R, Richardson A, Jones M.

Acute Med. 2015;14(3):119-21.

PMID:
26767200
8.

The Current Status of Neural Grafting in the Treatment of Huntington's Disease. A Review.

Wijeyekoon R, Barker RA.

Front Integr Neurosci. 2011 Dec 7;5:78. doi: 10.3389/fnint.2011.00078. eCollection 2011.

9.

Cognitive follow up of a small cohort of Huntington's disease patients over a 5 year period.

Mason SL, Wijeyekoon R, Swain R, Ho AK, Smith EL, Sahakian B, Barker RA.

Version 2. PLoS Curr. 2010 Sep 2 [revised 2010 Jan 1];2:RRN1174.

10.

Cell replacement therapy for Parkinson's disease.

Wijeyekoon R, Barker RA.

Biochim Biophys Acta. 2009 Jul;1792(7):688-702. doi: 10.1016/j.bbadis.2008.10.007. Epub 2008 Oct 25. Review.

Supplemental Content

Loading ...
Support Center